COSMO Pharmaceuticals N.V.
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for gastroenterology, dermatology, and healthtech. The company's therapeutic focus is on the oral and endoscopic treatment of colon diseases, including bowel diseases and colorectal cancer prevention, utilizing its proprietary MMX® technology. In addition to its own pipeline, Cosmo provides manufacturing services to other pharmaceutical companies. These services cover the production of solid, semi-solid, and liquid oral medicines and include process assessment, technology transfer, stability testing, market release, and regulatory documentation support.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-31 02:00 |
Cosmo mit hervorragenden Finanzergebnissen für 2023 - Erhöhte Betriebsergebnis-…
|
German | 40.8 KB | ||
| 2024-05-24 02:00 |
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General …
|
English | 8.0 KB | ||
| 2024-05-24 02:00 |
Aktionärinnen und Aktionäre von Cosmo Pharmaceuticals stimmen allen Tagesordnun…
|
German | 8.4 KB | ||
| 2024-04-29 02:00 |
Cosmo has received approval of an extension in respect of the publication and t…
|
English | 16.0 KB | ||
| 2024-04-29 02:00 |
Cosmo hat die Genehmigung für eine Verlängerung der Frist für die Veröffentlich…
|
German | 16.5 KB | ||
| 2024-04-25 02:00 |
Cosmo announces Leadership changes
|
English | 11.9 KB | ||
| 2024-04-25 02:00 |
Cosmo mit Veränderungen im Führungsteam
|
German | 13.4 KB | ||
| 2024-04-12 02:00 |
Cosmo and Medtronic unveil the future of AI in GI: Genius Summit 2024 reveals i…
|
English | 11.0 KB | ||
| 2024-04-12 02:00 |
Cosmo und Medtronic stellen die Zukunft der KI im Endoskopie-Bereich vor: Geni…
|
German | 11.5 KB | ||
| 2024-03-20 01:00 |
Cosmo reports excellent preliminary unaudited Full Year 2023 core financial res…
|
English | 27.1 KB | ||
| 2024-03-20 01:00 |
Cosmo meldet hervorragende vorläufige ungeprüfte Kern-Finanzergebnisse für das …
|
German | 28.3 KB | ||
| 2024-03-19 01:00 |
Cosmo Pharmaceuticals announces approval of Winlevi® in Australia
|
English | 10.7 KB | ||
| 2024-03-19 01:00 |
Cosmo Pharmaceuticals gibt Zulassung von Winlevi® in Australien bekannt
|
German | 11.0 KB | ||
| 2023-12-06 01:00 |
Cosmo confirms full redemption in cash of €175m Convertible Bonds
|
English | 6.4 KB | ||
| 2023-12-06 01:00 |
Cosmo bestätigt vollständige Rückzahlung in bar von EUR 175 Mio. Wandelanleihen
|
German | 6.6 KB |
Automate Your Workflow. Get a real-time feed of all COSMO Pharmaceuticals N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COSMO Pharmaceuticals N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COSMO Pharmaceuticals N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
